Idh-wildtype Gliomas

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-05-29
Clinical Trial Update: Treatment With AZD4547 for Recurrent Malignant Glioma Expressing FGFR-TACC Gene Fusion" [Phase 1, Phase 2]
A clinical trial evaluating AZD4547 for recurrent malignant glioma with FGFR-TACC gene fusions has completed Phase 1 and Phase 2.